Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor
As a ubiquitous enzyme overexpressed on the epithelium of the tumor, aminopeptidase N (APN) plays important roles in the angiogenesis and metastasis of the tumor. Bestatin as an effective inhibitor against APN is used in the ancillary treatment of various